We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $27.1B
1-Year Est. Return 57.21%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
10 Year Est. Return
AUM
$4.25B
AUM Growth
+$935M
Cap. Flow
+$872M
Cap. Flow %
20.54%
Top 10 Hldgs %
37.69%
Holding
613
New
34
Increased
490
Reduced
55
Closed
25

Top Buys

Rank Stock Value
1
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$78.8M
2
AAPL icon
Apple
AAPL
+$66.5M
3
NVDA icon
NVIDIA
NVDA
+$55.9M
4
MSFT icon
Microsoft
MSFT
+$53.9M
5
AMZN icon
Amazon
AMZN
+$37.1M

Sector Composition

Rank Sector Weight
1 Technology 33.68%
2 Consumer Discretionary 10.52%
3 Healthcare 10.01%
4 Communication Services 9.79%
5 Financials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAS icon
551
Hasbro
HAS
$12.7B
$325K 0.01%
5,808
+1,240
+27% +$80.9K
DCI icon
552
Donaldson
DCI
$10.1B
$324K 0.01%
+4,818
New +$355K
BEN icon
553
Franklin Templeton
BEN
$16.9B
$323K 0.01%
15,895
+3,731
+31% +$78.6K
TDY icon
554
Teledyne Technologies
TDY
$27.9B
$303K 0.01%
652
-4
-0.6% -$1.86K
SMR icon
555
NuScale Power
SMR
$3.38B
$297K 0.01%
+16,560
New +$342K
ULTA icon
556
Ulta Beauty
ULTA
$22.9B
$296K 0.01%
681
-5
-0.7% -$1.94K
ITCI
557
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$283K 0.01%
3,388
JANX icon
558
Janux Therapeutics
JANX
$993M
$280K 0.01%
5,223
-8,053
-61% -$426K
PARA
559
DELISTED
Paramount Global Class B
PARA
$280K 0.01%
26,730
+6,217
+30% +$66.8K
ZBRA icon
560
Zebra Technologies
ZBRA
$16.4B
$273K 0.01%
707
-5
-0.7% -$1.94K
FOX icon
561
Fox Class B
FOX
$25.1B
$267K 0.01%
+5,827
New +$245K
RLAY icon
562
Relay Therapeutics
RLAY
$4.17B
$266K 0.01%
64,655
+6,365
+11% +$34.6K
BEP icon
563
Brookfield Renewable
BEP
$8.67B
$265K 0.01%
+11,640
New +$297K
AGX icon
564
Argan
AGX
$5.56B
$263K 0.01%
+1,920
New +$264K
FDS icon
565
Factset
FDS
$9.78B
$253K 0.01%
526
-4
-0.8% -$1.9K
CPB icon
566
Campbell Soup
CPB
$6.44B
$252K 0.01%
6,076
+1,238
+26% +$55.9K
ESS icon
567
Essex Property Trust
ESS
$17.6B
$251K 0.01%
888
-6
-0.7% -$1.77K
SNA icon
568
Snap-on
SNA
$19.5B
$248K 0.01%
731
-5
-0.7% -$1.69K
BF.B icon
569
Brown-Forman Class B
BF.B
$11.9B
$243K 0.01%
6,405
+1,238
+24% +$54.5K
XENE icon
570
Xenon Pharmaceuticals
XENE
$5.57B
$240K 0.01%
+6,111
New +$253K
CGON icon
571
CG Oncology
CGON
$6.5B
$239K 0.01%
8,329
+817
+11% +$28K
CPRX
572
DELISTED
Catalyst Pharmaceutical
CPRX
$237K 0.01%
11,352
SRPT icon
573
Sarepta Therapeutics
SRPT
$2.13B
$236K 0.01%
1,943
+237
+14% +$29K
MOH icon
574
Molina Healthcare
MOH
$10.8B
$234K 0.01%
803
-6
-0.7% -$1.85K
ARVN icon
575
Arvinas
ARVN
$537M
$227K 0.01%
11,835
-4,915
-29% -$119K

Similar funds

NEOS Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, NEOS Investment Management held 613 positions worth $4.25B, up 28% from $3.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

NEOS Investment Management deployed $872M of net new capital in Q4 2024, opening 34 new positions and adding to 490 existing holdings. Its largest new stake was Palantir: 258,157 shares worth $19.5M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Insulet, an estimated $1.27M trimmed.

  • NEOS Investment Management's largest Q4 2024 buy was Palantir: 258,157 shares worth $19.5M.
  • NEOS Investment Management added most to Vanguard Russell 2000 ETF in Q4 2024, an estimated $78.8M increase.
  • NEOS Investment Management's biggest Q4 2024 reduction was Insulet, cutting an estimated $1.27M.
  • NEOS Investment Management fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q4 2024, selling an estimated $17.1M.
  • NEOS Investment Management's ten largest holdings make up 38% of its $4.25B portfolio in Q4 2024.
  • NEOS Investment Management opened 34 new positions and closed 25 in Q4 2024.
  • NEOS Investment Management's portfolio value rose 28% quarter-over-quarter to $4.25B.

Based on NEOS Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.